Iovance Biotherapeutics Inc (IOVA)

In the past 90 days, Iovance Biotherapeutics Inc. has reported no insider trading transactions, with a total count of zero for both buying and selling activities. The company's stock has experienced a significant decline of 48% over this period. The last earnings report, dated February 26, 2025, indicated a slight earnings beat of 2.84%. The next earnings date is scheduled for May 7, 2025.

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart
Ticker: IOVA Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-14 2024-11-12 S Sale

Maynard Ryan D

Non-Executive Director
50,000 -87.0%
10.06
USD 503,000 		50,000 -87.0% 10.06 USD 503,000
2024-02-20 2024-02-20 B Purchase

MCPEAK MERRILL A

Non-Executive Director
250,000 +356.4%
9.15
USD 2,287,500 		250,000 +356.4% 9.15 USD 2,287,500
2024-02-20 2024-02-20 B Purchase

Rothbaum Wayne P.

Non-Executive Director
5,000,000 +21.7%
9.15
USD 45,750,000 		5,000,000 +21.7% 9.15 USD 45,750,000
2024-02-20 2024-02-20 B Purchase

Dukes Iain D.

Non-Executive Director
32,000 +145.5%
9.15
USD 292,800 		32,000 +145.5% 9.15 USD 292,800
2023-09-19 2023-09-18 B Purchase

MCPEAK MERRILL A

Non-Executive Director
10,000 +4.2%
5.56
USD 55,600 		10,000 +4.2% 5.56 USD 55,600
2023-09-15 2023-09-15 B Purchase

Rothbaum Wayne P.

Non-Executive Director
5,000,000 +27.7%
5.30
USD 26,500,000 		5,000,000 +27.7% 5.30 USD 26,500,000
2022-12-22 2022-12-21 B Purchase

MCPEAK MERRILL A

Non-Executive Director
10,000 +16.6%
6.15
USD 61,500 		10,000 +16.6% 6.15 USD 61,500
2022-12-02 2022-12-02 B Purchase

Rothbaum Wayne P.

Non-Executive Director
10,000,000 +124.0%
6.50
USD 65,000,000 		10,000,000 +124.0% 6.50 USD 65,000,000
2022-11-30 2022-11-29 B Purchase

MCPEAK MERRILL A

Non-Executive Director
10,000 +4.4%
6.31
USD 63,100 		10,000 +4.4% 6.31 USD 63,100
2022-11-28 2022-11-28 B Purchase

MCPEAK MERRILL A

Non-Executive Director
10,000 +4.6%
6.18
USD 61,800 		10,000 +4.6% 6.18 USD 61,800
2022-11-28 2022-11-28 B Purchase

Vogt Frederick G

Interim CEO & General Counsel

Officer
1,000 +100.0%
5.98
USD 5,980 		1,000 +100.0% 5.98 USD 5,980
2022-11-28 2022-11-23 B Purchase

Dukes Iain D.

Non-Executive Director
10,000 +83.3%
6.10
USD 61,000 		10,000 +83.3% 6.10 USD 61,000
2022-06-02 2022-06-01 B Purchase

Rothbaum Wayne P.

Non-Executive Director
500,000 +6.6%
6.43
USD 3,215,500 		500,000 +6.6% 6.43 USD 3,215,500
2022-06-02 2022-06-01 B Purchase

Vogt Frederick G

Interim CEO & General Counsel

Officer
1,000 +inf%
6.44
USD 6,440 		1,000 +inf% 6.44 USD 6,440
2022-06-02 2022-05-31 B Purchase

MCPEAK MERRILL A

Non-Executive Director
10,000 +4.8%
6.80
USD 68,000 		10,000 +4.8% 6.80 USD 68,000
2022-06-02 2022-05-31 B Purchase

MCPEAK MERRILL A

Non-Executive Director
10,000 +98.5%
6.84
USD 68,400 		10,000 +98.5% 6.84 USD 68,400
2022-06-02 2022-05-31 B Purchase

Rothbaum Wayne P.

Non-Executive Director
500,000 +7.1%
6.77
USD 3,384,550 		500,000 +7.1% 6.77 USD 3,384,550
2022-06-02 2022-05-31 B Purchase

WEISER MICHAEL

Non-Executive Director
7,813 +7.5%
6.80
USD 53,128 		7,813 +7.5% 6.80 USD 53,128
2022-06-02 2022-05-31 B Purchase

WEISER MICHAEL

Non-Executive Director
2,187 +2.1%
6.79
USD 14,850 		2,187 +2.1% 6.79 USD 14,850
2022-06-02 2022-05-31 B Purchase

Maynard Ryan D

Non-Executive Director
7,500 +inf%
6.75
USD 50,588 		7,500 +inf% 6.75 USD 50,588
2018-12-20 2018-12-18 B Purchase

Dukes Iain D.

Non-Executive Director
12,000 +inf%
8.65
USD 103,796 		12,000 +inf% 8.65 USD 103,796
2018-12-14 2018-12-13 B Purchase

MCPEAK MERRILL A

Non-Executive Director
10,000 +2.2%
9.63
USD 96,273 		10,000 +2.2% 9.63 USD 96,273
2018-12-07 2018-12-06 B Purchase

Rothbaum Wayne P.

Non-Executive Director
300,000 +4.4%
9.86
USD 2,958,000 		300,000 +4.4% 9.86 USD 2,958,000
2018-12-07 2018-12-04 B Purchase

Rothbaum Wayne P.

Non-Executive Director
921,053 +15.8%
10.31
USD 9,496,056 		921,053 +15.8% 10.31 USD 9,496,056
2016-08-24 2016-08-22 S Sale

Hillsberg Sanford

Non-Executive Director
54,000 -35.1%
9.11
USD 491,740 		54,000 -35.1% 9.11 USD 491,740
2015-09-09 2015-09-08 S Sale

Hillsberg Sanford

Non-Executive Director
16,500 -9.7%
7.13
USD 117,645 		16,500 -9.7% 7.13 USD 117,645
2015-09-09 2015-09-04 S Sale

Hillsberg Sanford

Non-Executive Director
16,000 -8.6%
6.84
USD 109,440 		16,000 -8.6% 6.84 USD 109,440
2015-08-04 2015-08-03 S Sale

Hillsberg Sanford

Non-Executive Director
32,500 -14.8%
8.15
USD 264,875 		32,500 -14.8% 8.15 USD 264,875
2015-05-07 2015-05-06 S Sale

Hillsberg Sanford

Non-Executive Director
50,000 -18.6%
10.00
USD 500,000 		50,000 -18.6% 10.00 USD 500,000
2015-05-08 2015-05-01 S Sale

Ayer Capital Management, LP

Large shareholder
2,780,682 -49.6%
9.62
USD 26,752,385 		2,780,682 -49.6% 9.62 USD 26,752,385
2014-11-07 2014-11-06 S Sale

BRISTOL INVESTMENT FUND LTD

Large shareholder
100,000 -2.5%
690,000.00
USD 69,000,000,000 		100,000 -2.5% 690,000.00 USD 69,000,000,000
2013-11-12 2013-11-05 B Purchase

MCPEAK MERRILL A/

Non-Executive Director
50,000 +14.4%
2.00
USD 100,000 		50,000 +14.4% 2.00 USD 100,000
2013-11-07 2013-11-05 B Purchase

Singh Manish

President & CEO

Executive Director Large shareholder
125,000 +6.9%
2.00
USD 250,000 		125,000 +6.9% 2.00 USD 250,000
2011-09-26 2011-07-21 B Purchase

MCPEAK MERRILL A/

Non-Executive Director
10,000 +inf%
1.40
USD 14,000 		10,000 +inf% 1.40 USD 14,000
// ... existing code ... // ... rest of the file ...